The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Crises in Sickle Cell Disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 3×
“It has been hypothesized that sudden death during VOC may be due to fat embolization that has not yet resulted in MOFS.(25) Acute respiratory distress syndrome physiology can complicate MOFS in one-quarter of cases and require intubation and mechanical ventilation with standard lung-protective strategies (ie, low tida…”
BackgroundInfluentialEffect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866 · cited 9×
“Lending support to corticosteroid use is the known association between pediatric bronchial hyperreactivity journal.publications.chestnet.org and ACS58-60 and the high prevalence of decreased FEV1 in adult patients with SCD. 61 While intravenous corticosteroids prevented deterioration and reduced the need for transfusi…”
BackgroundInfluentialCerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members
Yawn, B. P., Buchanan, G. R., Afenyi-Annan, A. N., Ballas, S. K., Hassell, K. L., James, A. H., Jordan, L., Lanzkron, S. M., Lottenberg, R., Savage, W. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.10517 · Cited by 1,599
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Self-citationCauses and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422502 · Cited by 1,234
Wang, W. C., Ware, R. E., Miller, S. T., Iyer, R. V., Casella, J. F., Minniti, C. P., Rana, S., Thornburg, C. D., Rogers, Z. R., Kalpatthi, R. V., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60355-3 · Cited by 803
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573
Extracellular hemin crisis triggers acute chest syndrome in sickle mice
Ghosh, S., Adisa, O. A., Chappa, P., Tan, F., Jackson, K. A., Archer, D. R., & Ofori-Acquah, S. F. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64578 · Cited by 282
Research works printed but not linked: 97
- Akinola, 1992, Subclinical ischaemic episodes during the steady state of sickle cell anaemia, J Clin Pathol, 45, 902, 10.1136/jcp.45.10.902 · DOI
- Akinola, 1992, Rheological changes in the prodromal and established phases of sickle cell vaso-occlusive crisis, Br J Haematol, 81, 598, 10.1111/j.1365-2141.1992.tb02998.x · doi:10.1111/j.1365-2141.1992.tb02998.x
- Hebbel, 2000, Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies, N Engl J Med, 342, 1910, 10.1056/NEJM200006223422512 · DOI
- Hebbel, 1980, Erythrocyte adherence to endothelium in sickle-cell anemia: a possible determinant of disease severity, N Engl J Med, 302, 992, 10.1056/NEJM198005013021803 · DOI · Paper page
- Hebbel, 1980, Erythrocyte adherence to endothelium as a determinant of vasocclusive severity in sickle cell disease, Trans Assoc Am Physicians, 93, 94
- Hebbel, 1980, Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease, J Clin Invest, 65, 154, 10.1172/JCI109646 · DOI · Paper page
- Kaul, 1989, Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications, Proc Natl Acad Sci U S A, 86, 3356, 10.1073/pnas.86.9.3356 · DOI · Paper page
- Kaul, 1986, Vaso-occlusion by sickle cells: evidence for selective trapping of dense red cells, Blood, 68, 1162, 10.1182/blood.V68.5.1162.1162 · DOI
- Kaul, 2000, Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice, J Clin Invest, 106, 411, 10.1172/JCI9225 · DOI · Paper page
- Ataga, 2008, Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension, Haematologica, 93, 20, 10.3324/haematol.11763 · DOI · Paper page
- Belcher, 2003, Transgenic sickle mice have vascular inflammation, Blood, 101, 3953, 10.1182/blood-2002-10-3313 · DOI · Paper page
- Duits, 1996, Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis, Clin Immunol Immunopathol, 81, 96, 10.1006/clin.1996.0163 · DOI
- Platt, 2000, Sickle cell anemia as an inflammatory disease, J Clin Invest, 106, 337, 10.1172/JCI10726 · DOI · Paper page
- Lester, 1990, Cardiac abnormalities in children with sickle cell anemia, Chest, 98, 1169, 10.1378/chest.98.5.1169 · DOI
- Meloni, 2013, Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron, Am J Hematol, 88, 213
- Fitzhugh, 2010, Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease, Am J Hematol, 85, 36, 10.1002/ajh.21569 · DOI · Paper page
- Gladwin, 2012, Cardiovascular abnormalities in sickle cell disease, J Am Coll Cardiol, 59, 1123, 10.1016/j.jacc.2011.10.900 · DOI · Paper page
- Thompson, 2007, Albuminuria and renal function in homozygous sickle cell disease: observations from a cohort study, Arch Intern Med, 167, 701, 10.1001/archinte.167.7.701 · DOI
- Howard, 2015, Guideline on the management of acute chest syndrome in sickle cell disease, Br J Haematol, 169, 492
- Klings, 2014, An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease, Am J Respir Crit Care Med, 189, 727, 10.1164/rccm.201401-0065ST · DOI · Paper page
- Vichinsky, 1994, Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia, Blood, 83, 3107, 10.1182/blood.V83.11.3107.3107 · DOI · Paper page
- Novelli, 2012, Pulmonary embolism in sickle cell disease: a case-control study, J Thromb Haemost, 10, 760, 10.1111/j.1538-7836.2012.04697.x · DOI
- Hagger, 1995, Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls, Blood Coagul Fibrinolysis, 6, 93, 10.1097/00001721-199504000-00001 · DOI
- Tomer, 2001, Thrombogenesis in sickle cell disease, J Lab Clin Med, 137, 398, 10.1067/mlc.2001.115450 · DOI · Paper page
- Wang, 2010, Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro, Thromb Res, 126, e260, 10.1016/j.thromres.2010.07.009 · DOI
- Strouse, 2010, Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease, Blood, 116, 3431, 10.1182/blood-2010-05-282194 · DOI
- Emre, 1995, Effect of transfusion in acute chest syndrome of sickle cell disease, J Pediatr, 127, 901, 10.1016/S0022-3476(95)70025-0 · DOI
- Mekontso Dessap, 2008, Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease, Am J Respir Crit Care Med, 177, 646, 10.1164/rccm.200710-1606OC · DOI · Paper page
- Mallouh, 1988, Beneficial effect of blood transfusion in children with sickle cell chest syndrome, Am J Dis Child, 142, 178
- Hassell, 1994, Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes, Am J Med, 96, 155, 10.1016/0002-9343(94)90136-8 · DOI · Paper page
- Vlachaki, 2014, Thrombotic thrombocytopenic purpura or immune thrombocytopenia in a sickle cell/β+-thalassemia patient: a rare and challenging condition, Transfus Apher Sci, 51, 175, 10.1016/j.transci.2014.09.001 · DOI
- Venkata Sasidhar, 2010, Thrombotic thrombocytopenic purpura and multiorgan system failure in a child with sickle cell-hemoglobin C disease, Clin Pediatr (Phila), 49, 992, 10.1177/0009922809338314 · doi:10.1177/0009922809338314
- Shelat, 2010, Thrombotic thrombocytopenic purpura and sickle cell crisis, Clin Appl Thromb Hemost, 16, 224, 10.1177/1076029608323804 · DOI
- Lee, 2003, Life-threatening thrombotic thrombocytopenic purpura (TTP) in a patient with sickle cell-hemoglobin C disease, Ann Hematol, 82, 702, 10.1007/s00277-003-0715-0 · DOI
- Bolanos-Meade, 1999, Thrombotic thrombocytopenic purpura in a patient with sickle cell crisis, Ann Hematol, 78, 558
- Chinowsky, 1994, Thrombotic thrombocytopenic purpura associated with sickle cell-hemoglobin C disease, South Med J, 87, 1168, 10.1097/00007611-199411000-00025 · doi:10.1097/00007611-199411000-00025
- Chen, 2011, The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma, Blood, 117, 3680, 10.1182/blood-2010-08-302539 · DOI
- Novelli, 2013, Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease, Haematologica, 98, e132, 10.3324/haematol.2013.092635 · DOI
- Schnog, 2006, ADAMTS13 activity in sickle cell disease, Am J Hematol, 81, 492, 10.1002/ajh.20653 · DOI
- Boyd, 2006, Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia, Blood, 108, 2923, 10.1182/blood-2006-01-011072 · DOI · Paper page
- Knight-Madden, 2005, Asthma in children with sickle cell disease and its association with acute chest syndrome, Thorax, 60, 206, 10.1136/thx.2004.029165 · DOI · Paper page
- Field, 2011, Airway hyperresponsiveness in children with sickle cell anemia, Chest, 139, 563, 10.1378/chest.10-1243 · DOI
- Field, 2008, Longitudinal analysis of pulmonary function in adults with sickle cell disease, Am J Hematol, 83, 574
- Bernini, 1998, Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease, Blood, 92, 3082, 10.1182/blood.V92.9.3082 · DOI · Paper page
- Griffin, 1994, High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease, N Engl J Med, 330, 733, 10.1056/NEJM199403173301101 · DOI · Paper page
- Fartoukh, 2010, Early intermittent noninvasive ventilation for acute chest syndrome in adults with sickle cell disease: a pilot study, Intensive Care Med, 36, 1355, 10.1007/s00134-010-1907-4 · DOI
- Saarinen, 1986, Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia, Blood, 67, 1411, 10.1182/blood.V67.5.1411.1411 · doi:10.1182/blood.v67.5.1411.1411
- Tsitsikas, 2014, Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection, Blood Rev, 28, 23, 10.1016/j.blre.2013.12.002 · DOI
- Naymagon, 2015, Acute splenic sequestration crisis in adult sickle cell disease: a report of 16 cases, Hemoglobin, 39, 375, 10.3109/03630269.2015.1072550 · doi:10.3109/03630269.2015.1072550
- Rosse, 1990, Transfusion and alloimmunization in sickle cell disease: the Cooperative Study of Sickle Cell Disease, Blood, 76, 1431, 10.1182/blood.V76.7.1431.1431 · DOI · Paper page
- Vichinsky, 1990, Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood, N Engl J Med, 322, 1617, 10.1056/NEJM199006073222301 · DOI · Paper page
- Alarif, 1986, HLA-B35 is associated with red cell alloimmunization in sickle cell disease, Clin Immunol Immunopathol, 38, 178, 10.1016/0090-1229(86)90136-4 · doi:10.1016/0090-1229(86)90136-4
- Higgins, 2008, Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders, Blood, 112, 2546, 10.1182/blood-2008-03-146415 · doi:10.1182/blood-2008-03-146415
- Chou, 2013, High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors, Blood, 122, 1062, 10.1182/blood-2013-03-490623 · DOI · Paper page
- King, 1997, Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients’ red cells, Transfusion, 37, 376, 10.1046/j.1537-2995.1997.37497265337.x · doi:10.1046/j.1537-2995.1997.37497265337.x
- Talano, 2003, Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease, Pediatrics, 111, e661, 10.1542/peds.111.6.e661 · DOI · Paper page
- Win, 2001, Hyperhemolytic transfusion reaction in sickle cell disease, Transfusion, 41, 323, 10.1046/j.1537-2995.2001.41030323.x · doi:10.1046/j.1537-2995.2001.41030323.x
- Win, 2008, Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review, Transfusion, 48, 1231, 10.1111/j.1537-2995.2008.01693.x · doi:10.1111/j.1537-2995.2008.01693.x
- Sirchia, 1997, The sickle cell hemolytic transfusion reaction syndrome, Transfusion, 37, 1098, 10.1046/j.1537-2995.1997.371098016453.x · doi:10.1046/j.1537-2995.1997.371098016453.x
- Win, 2004, Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease, Hematology, 9, 433, 10.1080/10245330400001926 · doi:10.1080/10245330400001926
- Belizna, 2012, Arterial stiffness and stroke in sickle cell disease, Stroke, 43, 1129, 10.1161/STROKEAHA.111.635383 · DOI
- Kugler, 1993, Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications, Arch Neurol, 50, 629, 10.1001/archneur.1993.00540060059019 · DOI
- Strouse, 2006, Inverse correlation between cerebral blood flow measured by continuous arterial spin-labeling (CASL) MRI and neurocognitive function in children with sickle cell anemia (SCA), Blood, 108, 379, 10.1182/blood-2005-10-4029 · DOI
- DeBaun, 2012, Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure, Blood, 119, 3684, 10.1182/blood-2011-05-349621 · DOI · Paper page
- Kirkham, 2004, Stroke in children with sickle cell disease, Curr Treat Options Neurol, 6, 357, 10.1007/s11940-996-0028-4 · DOI
- Chien, 1987, Rheology of sickle cells and its role in microcirculatory dynamics, Prog Clin Biol Res, 240, 151
- Schmalzer, 1987, Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels: implications for transfusion, Transfusion, 27, 228, 10.1046/j.1537-2995.1987.27387235626.x · doi:10.1046/j.1537-2995.1987.27387235626.x
- Alkan, 2010, Cranial involvement in sickle cell disease, Eur J Radiol, 76, 151, 10.1016/j.ejrad.2009.05.032 · DOI
- Drew, 1993, General case of the day: moyamoya syndrome in a child with sickle cell disease, Radiographics, 13, 483, 10.1148/radiographics.13.2.8460234 · doi:10.1148/radiographics.13.2.8460234
- Geevasinga, 2014, Sickle cell disease and posterior reversible leukoencephalopathy, J Clin Neurosci, 21, 1329, 10.1016/j.jocn.2013.10.028 · DOI
- Henderson, 2003, Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease, Blood, 101, 415, 10.1182/blood-2002-04-1183 · DOI
- Banerjee, 2001, Sickle cell hepatopathy, Hepatology, 33, 1021, 10.1053/jhep.2001.24114 · DOI · Paper page
- Lee, 1996, Reverse sequestration in a case of sickle crisis, Postgrad Med J, 72, 487, 10.1136/pgmj.72.850.487 · doi:10.1136/pgmj.72.850.487
- Gaston, 1986, Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial, N Engl J Med, 314, 1593, 10.1056/NEJM198606193142501 · DOI · Paper page
- Baskin, 2013, Bacteremia risk and outpatient management of febrile patients with sickle cell disease, Pediatrics, 131, 1035, 10.1542/peds.2012-2139 · doi:10.1542/peds.2012-2139
- Quinn, 2010, Improved survival of children and adolescents with sickle cell disease, Blood, 115, 3447, 10.1182/blood-2009-07-233700 · DOI · Paper page
- Alkindi, 2012, Complications of PORT-A-CATH® in patients with sickle cell disease, J Infect Public Health, 5, 57, 10.1016/j.jiph.2011.10.004 · DOI
- Chulamokha, 2006, Bloodstream infections in hospitalized adults with sickle cell disease: a retrospective analysis, Am J Hematol, 81, 723, 10.1002/ajh.20692 · doi:10.1002/ajh.20692
- Zarrouk, 2006, Bloodstream infection in adults with sickle cell disease: association with venous catheters, Staphylococcus aureus, and bone-joint infections, Medicine (Baltimore), 85, 43, 10.1097/01.md.0000197023.46846.1c · DOI
- Wagner, 2004, Infectious complications of implantable venous access devices in patients with sickle cell disease, J Vasc Interv Radiol, 15, 375, 10.1097/01.RVI.0000121410.46920.6E · doi:10.1097/01.rvi.0000121410.46920.6e
- Green, 1992, Yersinia infections in patients with homozygous β-thalassemia associated with iron overload and its treatment, Pediatr Hematol Oncol, 9, 247, 10.3109/08880019209016592 · DOI
- Abcarian, 1991, Systemic Yersinia enterocolitica infection associated with iron overload and deferoxamine therapy, AJR Am J Roentgenol, 157, 773, 10.2214/ajr.157.4.1892033 · DOI
- Mazzoleni, 1991, Yersinia enterocolitica infection with ileal perforation associated with iron overload and deferoxamine therapy, Dig Dis Sci, 36, 1154, 10.1007/BF01297465 · DOI
- Gallant, 1986, Yersinia sepsis in patients with iron overload treated with deferoxamine, N Engl J Med, 314, 1643, 10.1056/NEJM198606193142514 · DOI
- Robins-Browne, 1983, Desferrioxamine and systemic yersiniosis, Lancet, 2, 1372, 10.1016/S0140-6736(83)91136-4 · DOI
- van Eijk, 2014, The effect of iron loading and iron chelation on the innate immune response and subclinical organ injury during human endotoxemia: a randomized trial, Haematologica, 99, 579, 10.3324/haematol.2013.088047 · DOI
- McAuley, 2010, High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya, Blood, 116, 1663, 10.1182/blood-2010-01-265249 · DOI
- Makani, 2010, Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization, Blood, 115, 215, 10.1182/blood-2009-07-233528 · DOI
- Hassell, 2010, Population estimates of sickle cell disease in the U.S, Am J Prev Med, 38, S512, 10.1016/j.amepre.2009.12.022 · DOI · Paper page
- Chang, 2008, Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion, Blood, 111, 915, 10.1182/blood-2007-04-084061 · DOI
- Turhan, 2004, Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes, Blood, 103, 2397, 10.1182/blood-2003-07-2209 · DOI
- Field, 2013, Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson, Blood, 121, 3329, 10.1182/blood-2012-11-465963 · DOI
- Maitre, 2015, Inhaled nitric oxide for acute chest syndrome in adult sickle cell patients: a randomized controlled study, Intensive Care Med, 41, 2121, 10.1007/s00134-015-4060-2 · DOI
- Gladwin, 2011, Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial, JAMA, 305, 893, 10.1001/jama.2011.235 · DOI · Paper page
- Morris, 2013, A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes, Haematologica, 98, 1375, 10.3324/haematol.2013.086637 · DOI · Paper page
- Machado, 2011, Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity, Blood, 118, 855, 10.1182/blood-2010-09-306167 · DOI · Paper page
- Schaer, 2013, Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins, Blood, 121, 1276, 10.1182/blood-2012-11-451229 · DOI · Paper page
Cited by
Kato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., Smith, W. R., Panepinto, J. A., Weatherall, D. J., Costa, F. F., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.10 · Cited by 1,501
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Self-citationLubeck, D., Agodoa, I., Bhakta, N., Danese, M., Pappu, K., Howard, R., Gleeson, M., Halperin, M., & Lanzkron, S. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.15374 · Cited by 336
Metadata
- Authors
- Novelli, E. M., & Gladwin, M. T.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 149
- Issue
- 4
- Pages
- 1082-1093
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2226775845
- Cited by
- 169
- References
- 24
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Crises in Sickle Cell Disease. https://app.cochat.ai/papers/10.1016/j.chest.2015.12.016
- The paper
- Novelli, E. M., & Gladwin, M. T. (2016). Crises in Sickle Cell Disease. Chest. https://doi.org/10.1016/j.chest.2015.12.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.